Lipum makes a share issue for faster progress

Being a European Commission Horizon 2020 beneficiary has a distinct positive impact on our development. The 2.2 M€ grant enables us to proceed faster towards a new drug against chronic inflammatory diseases. To further increase the momentum we are now raising additional funding by a share issue. Interested investors get a chance to join the exciting progress.

Like to learn more? »

2019-01-25T13:47:55+00:00